http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08198798-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9822bceff022feda91b10019125e70f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-733
filingDate 1995-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1437f4405d66d7548bdb74495c5fd6a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f27247f358c7dc9a7ff7c67dae88c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f15753f777297896ab110063088b12
publicationDate 1996-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08198798-A
titleOfInvention Antitumor indanone derivative
abstract (57) [Summary] [Objective] To provide a novel substance expected to be used as an antitumor agent. [Structure] The following general formula: An indanone derivative represented by. For example, it can be obtained by extracting and purifying Okinawan sponges. [Effect] It has a growth inhibitory activity against mouse lymphocytic leukemia cells (P388) and is expected to be used as an antitumor agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017009860-A1
priorityDate 1995-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9794813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234419125

Total number of triples: 23.